Universal Access and Affordable Medicines
Our campaign promotes transparency, accountability and the public interest in the field of pharmaceuticals. Our evidence-based advocacy aims to guarantee better and affordable medicines for Europe by questioning and reforming the current pharmaceutical business model and calling for better access to medicines for all.
About our work on access to medicines
Publications
EPHA Position on Medicine Shortages
EPHA Response to public consultation on EMA Regulatory Science to 2025
BeNeLuxA et al.: the best is yet to come
Latest Developments
Getting it right: COVID19 vaccines procurement
How should the European Commission and Member States manage the process of finding vaccines to tackle COVID-19? EPHA sets out 9 recommendations the European Commission and national governments should full to protect the public interest.
read moreEnsure equitable global access for treatments, vaccines and diagnostics resulting from the ACT Accelerator, over 70 organisations ask
EPHA joins over 70 organisations setting out principles and practices which should be implemented to ensure equitable global access for treatments, vaccines and diagnostics resulting from the ACT Accelerator
read moreEPHA joins calls for concrete actions to ensure access for all as pledges made to tackle COVID-19
EPHA joins calls for clear plans to increase the accountability and public ownership of this COVID-19 pledging initiative and
subsequent activities to ensure equal access for all.
Analysis & Opinion
Will pharma commit to delivering affordable therapeutics against COVID-19?
The coronavirus disease offers pharma companies the possibility for public trust in them to be restored. It remains to be seen if they will grasp this chance.
read moreThe Top 4 Issues in Medicines Policy for 2020
A snapshot of the themes and trends which will dominate the EU pharmaceutical policy in 2020.
read moreEU Review of Pharmaceutical Incentives – An Opportunity for Change
Ellen ‘t Hoen of Medicines Law and Policy on why it is time to change the system of pharmaceutical incentives in the EU
read moreGet monthly updates on key public health issues!
Events
Time for a new deal
14 November 2019
4th EPHA Universal Access and Affordable Medicines Forum. Challenging the status quo on medicines policy.
Past events
Putting health first
3 June 2019
Trailblazers, routes to better and affordable medicines by 2025
20 November 2018
How good are our medicines?
3 October 2018
Game changers for better and affordable medicines in Europe
21 November 2017
At the European Health Forum Gastein
How good are our medicines? An operational agenda for EU & national policy-makers
Medicines: new games, new rules - Pathways to better and affordable medicines.
“Healthy" innovation: putting patients before profits
Do you have a question?
Meet our Universal Access and Affordable Medicines Policy Lead.
Yannis Natsis
Policy Manager
yannis@epha.org
+32 2 233 3886